Dudediligence.

Rockwell Medical, Inc

RMTINASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$16,002

4 notices · 9,833 sh

Oct 2025 to Oct 2026

Reported ·

$7,572

3 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

2 of 3 reported sales carry the 10b5-1 box. Together they are 0.22% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: Strobeck Mark, Form 1442026-01-02: Neri Jesse, Form 1442026-01-02: Hunter Heather, Form 1442025-11-18: COOPER JOHN G, Form 1442025-11-18: COOPER JOHN G, sold2026-01-02: Neri Jesse, sold2026-01-02: Hunter Heather, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01Strobeck Mark, President and CEO$8,400
1,000 shplan 2026-05-19Form 4s on file end Jun 23144 ↗
2026-01-02Neri Jesse, SVP, FINANCE AND CFO$712
886 shplan 2024-12-13144 ↗
Form 4, 2026-01-05: sold 886 at $0.84 Form 4 ↗
2026-01-02Hunter Heather, Chief Operating Officer$2,318
2,868 shplan 2024-12-13144 ↗
Form 4, 2026-01-05: sold 2,868 at $0.84 Form 4 ↗
2025-11-18COOPER JOHN G, Director$4,572
5,079 shno plan date144 ↗
Form 4, 2025-11-18: sold 5,079 at $0.87 Form 4 ↗